Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iPACK Block for Knee Extension after TKA
NCT03353233Phase 4Completed
- Sponsor
- Duke University
- Start
- May 2018
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in knee osteoarthritis (OA), sponsored by Duke University. Started May 2018; status: completed.
02
Drugs
ropivacaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03353233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03353233.